Barley Extract Composition for JNK-Targeted Cognitive Deficit Treatment

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for cognitive deficits associated with tau protein hyperphosphorylation and oxidative stress in conditions like Alzheimer's disease are inadequate, as they do not effectively inhibit the activity of Jun N-terminal kinase (JNK) or address the underlying neuroinflammation and oxidative stress.

Innovation Solution

A composition comprising barley extract is used as an active ingredient to inhibit JNK activity, thereby preventing or treating cognitive deficits and conditions associated with tau protein hyperphosphorylation, neuroinflammation, and oxidative stress, utilizing methods of extraction and formulation into pharmaceutical or food compositions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for cognitive deficits, then treatment options are available, but they do not effectively inhibit JNK activity or address underlying neuroinflammation and oxidative stress

Engineering Contradiction:

Improveeffectiveness of treatmentVSAvoidJNK activity, neuroinflammation, oxidative stress

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the biochemical parameters of the treatment by using barley extract that specifically inhibits JNK activity and modulates oxidative stress markers. The composition alters the biochemical environment in the brain by reducing JNK phosphorylation and enhancing antioxidant enzymes, thereby resolving the contradiction between available treatment options and their ineffective targeting of harmful factors.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The barley extract acts as an intermediary substance that mediates between the cognitive deficit and the underlying harmful factors. It specifically targets JNK activity and oxidative stress as intermediate mechanisms, providing a more effective treatment approach by addressing the root causes rather than just symptoms.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Reliability

If tau protein hyperphosphorylation is addressed, then cognitive deficits may improve, but current treatments do not effectively reduce hyperphosphorylation

Engineering Contradiction:

Improvereduction of tau hyperphosphorylationVSAvoidprecision of treatment mechanism

Core Design Contradiction:

ReliabilityVSManufacturing precision

Solution Approach 1:

The patent employs feedback mechanisms by monitoring and addressing tau hyperphosphorylation levels. The barley extract composition provides feedback control by continuously reducing JNK activity and oxidative stress, which are the drivers of tau hyperphosphorylation, thereby achieving precise control over the treatment outcome.

Inventive Principle:

Principle #23Feedback

Solution Approach 2:

The patent replaces conventional treatment mechanisms with a biochemical approach using barley extract that specifically targets the phosphorylation pathways. This substitution of treatment mechanism enables more precise control over tau protein modification, directly addressing the hyperphosphorylation issue with greater effectiveness.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If oxidative stress and neuroinflammation are targeted, then therapeutic benefits may be achieved, but current treatments do not sufficiently address these factors

Engineering Contradiction:

Improvetherapeutic benefitVSAvoidoxidative stress, neuroinflammation

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful effects of oxidative stress and neuroinflammation into beneficial outcomes by using barley extract that specifically targets these pathways. The composition enhances antioxidant enzyme activity and reduces inflammatory markers, thereby transforming the treatment approach from merely suppressing symptoms to actively reversing the harmful biochemical environment.

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS20260027175A1Compositions and methods for treating a cognitive deficit

Publication Date: 2026.01.29 DR DOZO LAB

AI summary

The present disclosure relates to compositions and methods for preventing or treating a cognitive deficit in a subject. The compositions comprise a barley extract as an active ingredient.